Date: April 5, 2020
By: Daniel Hamilton
The global public health crisis sparked by coronavirus is unprecedented in its scale and voracity. If there are any lessons that must be learned, even in this early stage of fighting the pandemic, it is the critical importance of countries, large and small, working together to share data, trends and best practice in R&D and clinical excellence.
The World Health Organisation (WHO) has long been the subject of many criticisms as to its day-to-day management and efficacy and yet, when it comes to playing global role in fighting coronavirus, it remains the only game in town.
For this reason, the repeated exclusion of Taiwan from the WHO’s deliberations as a result of pressure from the People’s Republic of China has ceased to be just another chapter in a fratricidal war between two groups with a differing view of Chinese statehood and has now become a risk to international public health.
Since its first detection in the country in January, quick actions on the part of Taiwanese authorities have resulted in only three recorded deaths – a fact that healthcare experts put down to its robust cross-referencing of overseas travel and health records and robust quarantining of carriers. [FULL STORY]